Roma has compiled one of the largest repositories of covered 19 research in the world, containing more than 410 thousand articles by early may. The goal is for the data base, called covet 19, living over view of evidence, to be the raw material for evidence syntheses. Drawing on this and other sources, a handful of groups are developing living systematic reviews.
A deluge of trials has stress-tested the systems that produce evidence.
Around the world, researchers have raced to test therapies to treat COVID-19. The speed and urgency of this task has revealed both the weaknesses in the collection and use of research-based evidence, and how well-run trials have helped save lives.
This is an audio version of our feature: How COVID broke the evidence pipeline
Hosted on Acast. See acast.com/privacy for more information.